Document is current
Any future updates will be listed below
-
Authors
Legge, Sophie E. https://orcid.org/0000-0001-6617-0289
Pardiñas, Antonio F. https://orcid.org/0000-0001-6845-7590
Helthuis, Marinka
Jansen, John A.
Jollie, Karel
Knapper, Steven
MacCabe, James H. https://orcid.org/0000-0002-6754-1018
Rujescu, Dan
Collier, David A. https://orcid.org/0000-0003-4087-1559
O’Donovan, Michael C. https://orcid.org/0000-0001-7073-2379
Owen, Michael J https://orcid.org/0000-0003-4798-0862
Walters, James T. R.
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (G0800509, MR/L011794/1, G0800509, MR/L011794/1, G0800509, MR/L011794/1)
EC | Seventh Framework Programme (279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227)
- License Information
-
More Information
Article History
Received: 30 July 2018
Revised: 13 September 2018
Accepted: 26 November 2018
First Online: 15 January 2019
Compliance with ethical standards
:
: DAC is a full-time employee and stockholder of Eli Lilly and Company. MH, JAJ and KJ are full-time employees of Leyden Delta B.V. The remaining authors declare that they have no conflict of interest.
